Volume 8,Issue 6,2022 Table of Contents

   
Other Issues:  
  

论著

Hypoxia-inducible factor-2α and its missense mutations: potential role in HCC diagnosis, progression, and prognosis and underlying mechanism
  Jun Li,Yibo Yan,Ganxin Wang and Zaozao Huang
  2022,8(6):267-275 [Abstract]  [View PDF(763.21 K)]
  
Construction and validation of a prognostic risk model for uterine corpus endometrial carcinoma based on alternative splicing events
  Yi Cheng,Long Li,Chen Gong and Kai Qin
  2022,8(6):276-284 [Abstract]  [View PDF(2.57 M)]
  
A novel derivative of Genistein inhibits proliferation of ovarian cancer HO-8910 cells by regulating reactive oxygen species
  Yanping Gao,Zhiyong Dong and Jun Bai
  2022,8(6):285-292 [Abstract]  [View PDF(985.66 K)]
  
Downregulated lncRNA DRAIC enhances the radiotherapy sensitivity of human HCC cell line HepG2 by targeting miR-223-3p
  Shuyan Li,Jian Zhang,Zhengming Wang and Wenjun Li
  2022,8(6):293-300 [Abstract]  [View PDF(1.49 M)]
  
Treatment-related adverse events of combined anti-angiogenic and immune checkpoint inhibitors: systematic review and meta-analysis
  Lian Chen,Ling Wu,Zhang Lu,Qin Huang and Liu Huang
  2022,8(6):301-310 [Abstract]  [View PDF(674.41 K)]
  

病例报道

Case report of a mixed pulmonary large cell neuroendocrine carcinoma
  Xiaoying Quan,Xiaoyan Chen,Lei Lei,Xiaoli Jia,Chunzhi Wu and Bin Ye
  2022,8(6):311-313 [Abstract]  [View PDF(511.24 K)]
  
Adnexal tumor found during a brain-dead donor organ retrieval: a case report
  Bo Zhang,Huibo Shi,Jing Xu,Xiaoqin Li,Mengjun Zeng,Ying Tao,Xing Wu and Jipin Jiang
  2022,8(6):314-317 [Abstract]  [View PDF(736.92 K)]